|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
138,140,000 |
Market
Cap: |
142.28(M) |
Last
Volume: |
3,241,097 |
Avg
Vol: |
3,334,946 |
52
Week Range: |
$0.937 - $1.11 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 807 |
Guru Rank Value : 1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
50,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
Total People Sold |
0 |
0 |
1 |
7 |
Total Sell Transactions |
0 |
0 |
1 |
19 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gustafson Kurt A |
EVP & Chief Financial Officer |
|
2018-03-28 |
4 |
AS |
$16.35 |
$71,123 |
D/D |
(4,350) |
187,193 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-03-27 |
4 |
AS |
$17.10 |
$513,000 |
I/I |
(30,000) |
1,555,963 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-03-26 |
4 |
AS |
$17.34 |
$520,200 |
I/I |
(30,000) |
1,585,963 |
|
- |
|
Gustafson Kurt A |
EVP & Chief Financial Officer |
|
2018-03-26 |
4 |
AS |
$17.38 |
$22,594 |
D/D |
(1,300) |
191,543 |
|
- |
|
Riga Thomas J |
Chief Operating Officer |
|
2018-03-26 |
4 |
AS |
$17.41 |
$3,830 |
D/D |
(220) |
251,476 |
|
- |
|
Gustafson Kurt A |
EVP & Chief Financial Officer |
|
2018-03-22 |
4 |
AS |
$18.13 |
$47,868 |
D/D |
(2,640) |
192,843 |
|
- |
|
Turgeon Joseph W. |
CEO & President |
|
2018-03-22 |
4 |
AS |
$18.17 |
$56,327 |
D/D |
(3,100) |
332,884 |
|
- |
|
Krassner Stuart Mitchell |
Director |
|
2018-03-21 |
4 |
S |
$18.64 |
$78,278 |
D/D |
(4,200) |
79,057 |
|
- |
|
Krassner Stuart Mitchell |
Director |
|
2018-03-21 |
4 |
OE |
$2.55 |
$76,500 |
D/D |
30,000 |
83,257 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-03-09 |
4 |
OE |
$2.55 |
$1,275,000 |
I/I |
500,000 |
1,787,542 |
|
- |
|
Turgeon Joseph W. |
CEO & President |
|
2018-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
38,889 |
335,984 |
|
- |
|
Gustafson Kurt A |
EVP & Chief Financial Officer |
|
2018-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
19,445 |
195,483 |
|
- |
|
Riga Thomas J |
Chief Operating Officer |
|
2018-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
251,696 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
200,652 |
200,652 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-01-09 |
4 |
D |
$18.03 |
$63,110,301 |
D/D |
(3,500,294) |
3,488,337 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2018-01-09 |
4 |
OE |
$3.92 |
$39,510,784 |
D/D |
5,199,584 |
6,988,631 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2017-12-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,431 |
67,144 |
|
- |
|
Shrotriya Rajesh C Md |
Chairman & CEO |
|
2017-11-30 |
4 |
GD |
$19.04 |
$526,761 |
D/D |
27,666 |
1,829,047 |
|
- |
|
Shrotriya Rajesh C Md |
Chairman & CEO |
|
2017-11-30 |
4 |
D |
$19.04 |
$841,777 |
I/I |
(44,211) |
170,473 |
|
- |
|
Shrotriya Rajesh C Md |
Chairman & CEO |
|
2017-11-30 |
4 |
OE |
$3.15 |
$315,000 |
I/I |
100,000 |
214,684 |
|
- |
|
Shrotriya Rajesh C Md |
Director |
|
2017-08-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
774 |
68,575 |
|
- |
|
Krassner Stuart Mitchell |
Director |
|
2017-07-17 |
4 |
D |
$7.53 |
$106,828 |
D/D |
(14,187) |
53,257 |
|
- |
|
Krassner Stuart Mitchell |
Director |
|
2017-07-17 |
4 |
OE |
$6.90 |
$103,500 |
D/D |
15,000 |
67,444 |
|
- |
|
Maida Anthony E III |
Director |
|
2017-07-17 |
4 |
D |
$7.53 |
$106,828 |
D/D |
(14,187) |
22,988 |
|
- |
|
Maida Anthony E III |
Director |
|
2017-07-17 |
4 |
OE |
$6.90 |
$103,500 |
D/D |
15,000 |
37,175 |
|
- |
|
658 Records found
|
|
Page 13 of 27 |
|
|